GLI1 and cancer: Recently, the study of Lin et al. [17] showed those fractions with sutherlandioside D to have high anti-tumorogenic effects against prosrate cancer using an in vivo setup suggesting that these anti-cancer effects are exerted through Gli/Hn signaling pathways that control cell patterning and formation plus proliferation in animal cells.